| Active substance |
Myostan |
| Also known as |
YK11, YK-11 |
| Blood pressure |
Can potentially elevate blood pressure |
| Chemical name |
(17-alpha,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester |
| Dosage (medical) |
Not medically approved or prescribed |
| Dosage (sports) |
Typically 5-10 mg per day |
| Effects |
Increases muscle mass, strength, and overall physical performance |
| Formula |
C25H34O6 |
| Half-life |
Approximately 6-10 hours |
| Hepatotoxicity |
Moderate risk |
| Lab Test |
Detection via specific blood tests for YK-11 metabolites |
| Main action |
Selective Androgen Receptor Modulator (SARM) |
| Side effects |
Potential liver toxicity, suppression of natural testosterone production, hair loss, joint pain |
| Storage conditions |
Store at room temperature, away from moisture and direct sunlight |
| Substance class |
Synthetic steroid |
| Trade name |
Not commercially available under any trade name |
| Use in sports |
Commonly used as a performance-enhancing drug |
| Water Retention |
Minimal to none |
| Active ingredient, mg |
5 |
| Release form |
Tablets |
| 1 Pill, mg |
5 |
| Manufacturer |
Driada Medical |
| Packing |
Packaging (50 tablets) |
